Annual report pursuant to Section 13 and 15(d)

COMMITMENTS AND CONTINGENCIES (Details)

v3.22.0.1
COMMITMENTS AND CONTINGENCIES (Details)
12 Months Ended
Dec. 31, 2021
USD ($)
$ / shares
shares
Number of days granted to purchase from the close of initial public offering 45 days
Underwriting cash discount per unit $ 0.20
Aggregate underwriter cash discount | $ $ 4,000,000
Deferred Fee Per Unit $ 0.35
Over-allotment option  
Number of units sold | shares 3,000,000
Deferred Fee Per Unit $ 0.55
Aggregate deferred underwriting fee payable | $ $ 8,650,000